Biocause's 400 000 T/A DME Project Came on Stream      

Hubei Biocause Pharmaceutical Co., Ltd. (Biocause, SZ: 000627) has put its 400 000 t/a dimethyl ether (DME) project into operation in Jingmen of Hubei province, bringing Biocause's DME capacity to 500 000 t/a. The company released on October 26th.
   The whole project was conducted in two phases. The first phase - a 200 000 t/a DME line was completed and came on stream in June 2008. (CCR2008 No. 21) The second phase - an additional 200 000 t/a DME unit has normally operation now.   
   Biocause has ambitions to be a leader in new energy field in China, towards DME production capacity of 1 million t/a.